Discover the latest advancements, network with peers, and form new connections.
Join FACT and ISCT-ANZ in Queenstown, NZ, this August for the

ISCT ANZ 2024 Regional Meeting and pre-conference FACT Accreditation Workshop!

Register for both meetings and receive a 50% discount! Use code ISCTANZ24 at checkout.

Use the button below to register for the ISCT-ANZ Regional Meeting in Queenstown, NZ.


Return to this window and click the Finalize Your Registration process.

Note: You must have your confirmation # from ISCT, or your credit card will be billed the remaining amount due.



Phyllis I. Warkentin, MD

Chief Medical Officer


Topic: Overview of the FACT Accreditation Process

Dr. Phyllis I. Warkentin is a founding member of FACT and has been serving as a board member and chief medical officer since the organization’s inception. In addition to her work with FACT, Dr. Warkentin has been the director of the unrelated bone marrow transplantation program at the University of Nebraska Medical Center since 1988 and a professor of pediatrics and pathology/microbiology at the University of Nebraska Medical Center since 1994. She attended medical school at the University of Minnesota, where she subsequently completed a residency in pediatrics and fellowships in pediatric hematology/oncology and blood banking.

No Disclosures

Joseph Schwartz, MD MPH

Director of Transfusion Services

H. Lee Moffit Cancer Center & Research Institute

TOPIC: Overview of Fact Accreditation Process
TOPIC: Leveraging FACT Accreditation to Reduce Audit Burdens

Dr. Joseph Schwartz is the Director of Transfusion Medicine Services at the Moffitt Cancer Center in Tampa, FL. Dr. Schwartz is the Chair of the FACT Technology Committee and Co-Chair of the FACT Cellular Therapy Accreditation and Cord Blood Bank Accreditation Committees. In addition, he is a member of the FACT Standards Steering and Education committees. In the past, he served on the FACT Board of Directors. Dr. Schwartz has participated as an Apheresis and Marrow Collection, Cord Blood Banking, and Cord Blood Collection Inspector since 2006.

No Disclosures.

Guy Klamer, PhD

Speaker Title

Speaker Company

TOPIC: Key to Compliance Application Success (w/Activity: Evaluating Compliance)

Nothing to disclose

Vicki Antonenas, BSc MSc (Med)

Speaker Title

Blood Transplant and Cell Therapies Laboratory, Westmead Hospital in Sydney Australia

Topic: What to Expect During an Inspection

Vicki is the Laboratory Director of the Blood Transplant and Cell Therapies Laboratory at Westmead Hospital, which is the largest laboratory in Sydney, preparing more than 380 products each year for infusions and performing over 1000 laboratory procedures for adult and pediatric patients undergoing transplantation and cell therapies to four Sydney BMT Hospitals. The laboratory also performs complex and specialized procedures involving extensive manipulation. The laboratory also receives and releases Immune Effector Cells, including CAR T cells. Vicki is also involved and responsible for all the administrative and scientific aspects of cellular cell processing and manipulation for HPCs and IEC, including compliance with national and international standards. She has been in this role for over 30 years at Westmead Hospital and has developed strong collaborations with national and international colleagues. Her interests have always been improving, teaching, and advancing all cell processing procedures for blood transplantation and cellular therapy. Her input and commitment to FACT and ISCT continue to grow. Vicki has been an active FACT inspector for cell processing laboratories for more than 12 years. 

Nothing to Disclose

Jessica Sue, BSc, MHSM

Speaker Title

Speaker Company

Topic: Correction of Deficiencies

Jessica Sue is the Quality Manager at the Sydney Cord Blood Bank, a FACT-accredited and TGA-licensed public cord blood bank. Jessica has gained industry knowledge in the regulatory requirements of cellular therapy organizations through her involvement in the FACT Quality Management Committee and ISCT ANZ Legal and Regulatory Affairs Committee, as a trainee FACT Inspector, and at various FACT Accreditation and Training Workshops. Jessica is also a founding co-chair of the ISCT ANZ Early Stage Professional (ESP) Subcommittee and holds a position with the global ESP Committee.   

Nothing to disclose.

Cheryl Hutchins, PhD

Laboratory Director, BMT Laboratory

Royal Brisbane & Women's Hospital

Topic: Program Perspectives - Achieving Outcomes

For 30 years, Cheryl has been the Laboratory Director of the Cellular Therapy Laboratory, Cancer Care Services at the Royal Brisbane & Women’s Hospital, the first haemopoietic progenitor cell transplant program accredited by FACT in Australia. The Cellular Therapy Laboratory is a large processing facility for the haemopoietic progenitor cell transplant and immune effector cell programs at the Royal Brisbane & Women’s Hospital and Queensland Children’s Hospital. As part of the HPCT program, the laboratory performs complex processing procedures such as CD34+ cell selection, TCRαβ depletion, or CD45RA depletion. As part of the CAR-T cell program, the laboratory has developed point-of-care production of CAR-T cells to provide treatment options for patients ineligible for government-funded commercial CAR-T cell therapies. 

Nothing to disclose.

Ngaire Elwood, PhD, BSc(Hons), MAICD

Speaker Title

Speaker Organization

Topic: Maintaining FACT Readiness

Nothing to disclose.

  • Register
    • Applicant - $250
    • Auditor - Free!
    • Committee Member - Free!
    • Consultant - Free!
    • FACT Staff - Free!
    • Inspector - Free!
    • Inspector Trainee - Free!
    • Non-member - $250
    • Industry Representative - $500
    • Fellow - $150

Already registered?
Log in to access.

Log In


Live In-Person Event
Discover the latest advancements, network with peers, and form new connections. Join FACT and ISCT-ANZ in Queenstown, NZ this August for the ISCT ANZ 2024 Regional Meeting and FACT Accreditation Workshop! You must register to access.